Abstract
To tackle the burden of obesity-induced cardiometabolic disease, the scientific community relies on accurate and reproducible adiposity measurements in the clinic. These measurements guide our understanding of underlying biological mechanisms and clinical outcomes of human trials. However, measuring adiposity and adipose tissue distribution in a clinical setting can be challenging, and different measurement methods pose important limitations. BMI is a simple and high-throughput measurement, but it is associated relatively poorly with clinical outcomes when compared with waist-to-hip and sagittal abdominal diameter measurements. Body composition measurements by dual energy X-ray absorptiometry or MRI scans would be ideal due to their high accuracy, but are not high-throughput. Another important consideration is that adiposity measurements vary between men and women, between adults and children, and between people of different ethnic backgrounds. In this Perspective article, we discuss how these critical challenges can affect our interpretation of research data in the field of obesity and the design and implementation of clinical guidelines.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abdelaal, M., le Roux, C. W. & Docherty, N. G. Morbidity and mortality associated with obesity. Ann. Transl. Med. 5, 161 (2017).
Neeland, I. J. et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 308, 1150–1159 (2012).
Hagberg, C. E. & Spalding, K. L. White adipocyte dysfunction and obesity-associated pathologies in humans. Nat. Rev. Mol. Cell Biol. 25, 270–289 (2024).
Frank, A. P., de Souza Santos, R., Palmer, B. F. & Clegg, D. J. Determinants of body fat distribution in humans may provide insight about obesity-related health risks. J. Lipid Res. 60, 1710–1719 (2019).
AlZaim, I., de Rooij, L., Sheikh, B. N., Borgeson, E. & Kalucka, J. The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity. Nat. Rev. Endocrinol. 19, 691–707 (2023).
Börgeson, E., Boucher, J. & Hagberg, C. E. Of mice and men: pinpointing species differences in adipose tissue biology. Front. Cell Dev. Biol. 10, 1003118 (2022).
Duren, D. L. et al. Body composition methods: comparisons and interpretation. J. Diabetes Sci. Technol. 2, 1139–1146 (2008).
Salmon-Gomez, L., Catalan, V., Fruhbeck, G. & Gomez-Ambrosi, J. Relevance of body composition in phenotyping the obesities. Rev. Endocr. Metab. Disord. 24, 809–823 (2023).
NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627–2642 (2017).
Lister, N. B. et al. Child and adolescent obesity. Nat. Rev. Dis. Prim. 9, 24 (2023).
Jebeile, H., Kelly, A. S., O’Malley, G. & Baur, L. A. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 10, 351–365 (2022).
Panera, N. et al. Genetics, epigenetics and transgenerational transmission of obesity in children. Front. Endocrinol. 13, 1006008 (2022).
Santos, L. P., Santos, I. S., Matijasevich, A. & Barros, A. J. D. Changes in overall and regional body fatness from childhood to early adolescence. Sci. Rep. 9, 1888 (2019).
Jerome, M. L., Valcarce, V., Lach, L., Itriago, E. & Salas, A. A. Infant body composition: a comprehensive overview of assessment techniques, nutrition factors, and health outcomes. Nutr. Clin. Pract. 38, S7–S27 (2023).
Larqué, E. et al. From conception to infancy – early risk factors for childhood obesity. Nat. Rev. Endocrinol. 15, 456–478 (2019).
Hills, A. P. et al. Body composition from birth to 2 years. Eur. J. Clin. Nutr. 76, 1165–1171 (2023).
Yousuf, E. I. et al. Growth and body composition trajectories in infants meeting the WHO growth standards study requirements. Pediatr. Res. 92, 1640–1647 (2022).
Lampl, M. & Thompson, A. L. Growth chart curves do not describe individual growth biology. Am. J. Hum. Biol. 19, 643–653 (2007).
Robertson, J. et al. Higher body mass index in adolescence predicts cardiomyopathy risk in midlife. Circulation 140, 117–125 (2019).
Marcus, M. D., Foster, G. D. & El Ghormli, L. Stability of relative weight category and cardiometabolic risk factors among moderately and severely obese middle school youth. Obesity 22, 1118–1125 (2014).
Felix, J. et al. Health related quality of life associated with extreme obesity in adolescents – results from the baseline evaluation of the YES-study. Health Qual. Life Outcomes 18, 58 (2020).
Chooi, Y. C., Ding, C. & Magkos, F. The epidemiology of obesity. Metabolism 92, 6–10 (2019).
Martos-Moreno, G. A. et al. Ethnicity strongly influences body fat distribution determining serum adipokine profile and metabolic derangement in childhood obesity. Front. Pediatr. 8, 551103 (2020).
Saltzman, E. & Karl, J. P. Nutrient deficiencies after gastric bypass surgery. Annu. Rev. Nutr. 33, 183–203 (2013).
Hoeltzel, G. D. et al. How safe is adolescent bariatric surgery? An analysis of short-term outcomes. J. Pediatr. Surg. 57, 1654–1659 (2022).
Malhotra, S. et al. Bariatric surgery in the treatment of adolescent obesity: current perspectives in the United States. Expert. Rev. Endocrinol. Metab. 16, 123–134 (2021).
Goedecke, J. H. & Mendham, A. E. Pathophysiology of type 2 diabetes in sub-Saharan Africans. Diabetologia 65, 1967–1980 (2022).
Cooper, L. B. et al. Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registry. Eur. J. Heart Fail. 20, 1281–1289 (2018).
Wright, A. K. et al. Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes. Diabetologia 63, 1542–1553 (2020).
Yaghootkar, H., Whitcher, B., Bell, J. D. & Thomas, E. L. Ethnic differences in adiposity and diabetes risk – insights from genetic studies. J. Intern. Med. 288, 271–283 (2020).
Sun, C., Kovacs, P. & Guiu-Jurado, E. Genetics of body fat distribution: comparative analyses in populations with European, Asian and African ancestries. Genes 12, 841 (2021).
Volgman, A. S. et al. Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association. Circulation 138, e1–e34 (2018).
Nono Nankam, P. A., Nguelefack, T. B., Goedecke, J. H. & Blüher, M. Contribution of adipose tissue oxidative stress to obesity-associated diabetes risk and ethnic differences: focus on women of African ancestry. Antioxidants 10, 622 (2021).
Lean, M. E. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391, 541–551 (2018).
Taheri, S. et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 8, 477–489 (2020).
Sattar, N. et al. Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby). Lancet Reg. Health Southeast. Asia 9, 100111 (2023).
Turner, B. E., Steinberg, J. R., Weeks, B. T., Rodriguez, F. & Cullen, M. R. Race/ethnicity reporting and representation in US clinical trials: a cohort study. Lancet Reg. Health Am. 11, 100252 (2022).
Blue, M. N. M., Tinsley, G. M., Ryan, E. D. & Smith-Ryan, A. E. Validity of body-composition methods across racial and ethnic populations. Adv. Nutr. 12, 1854–1862 (2021).
Kautzky-Willer, A., Leutner, M. & Harreiter, J. Sex differences in type 2 diabetes. Diabetologia 66, 986–1002 (2023).
Wong, N. D. & Sattar, N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat. Rev. Cardiol. 20, 685–695 (2023).
Palmer, B. F. & Clegg, D. J. The sexual dimorphism of obesity. Mol. Cell Endocrinol. 402, 113–119 (2015).
Chang, E., Varghese, M. & Singer, K. Gender and sex differences in adipose tissue. Curr. Diab Rep. 18, 69 (2018).
Lumish, H. S., O’Reilly, M. & Reilly, M. P. Sex differences in genomic drivers of adipose distribution and related cardiometabolic disorders: opportunities for precision medicine. Arterioscler. Thromb. Vasc. Biol. 40, 45–60 (2020).
Abildgaard, J. et al. Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass. Sci. Rep. 11, 14750 (2021).
Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J. & Joham, A. E. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care 42, 560–567 (2019).
Traish, A. M. Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy – a narrative review. Sex. Med. Rev. 11, 384–394 (2023).
Henninger, A. M., Eliasson, B., Jenndahl, L. E. & Hammarstedt, A. Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS ONE 9, e105262 (2014).
Succurro, E. et al. Relative risk of cardiovascular disease is higher in women with type 2 diabetes, but not in those with prediabetes, as compared with men. Diabetes Care 43, 3070–3078 (2020).
Bancks, M. P. et al. Sex differences in cardiovascular risk factors before and after the development of type 2 diabetes and risk for incident cardiovascular disease. Diabetes Res. Clin. Pract. 166, 108334 (2020).
Wong, N. D. et al. Sex differences in coronary artery calcium and mortality from coronary heart disease, cardiovascular disease, and all causes in adults with diabetes: the Coronary Calcium Consortium. Diabetes Care 43, 2597–2606 (2020).
Ohkuma, T., Iwase, M., Fujii, H. & Kitazono, T. Sex differences in cardiovascular risk, lifestyle, and psychological factors in patients with type 2 diabetes: the Fukuoka Diabetes Registry. Biol. Sex. Differ. 14, 32 (2023).
World Health Organization. The SuRF report 2. Surveillance of chronic disease risk factors: Country-level data and comparable estimates. iris.who.int/bitstream/handle/10665/43190/9241593024_eng.pdf (2005).
Tang, Y. et al. Age-related changes in body composition and bone mineral density and their relationship with the duration of diabetes and glycaemic control in type 2 diabetes. Diabetes Metab. Syndr. Obes. 13, 4699–4710 (2020).
Kuk, J. L., Saunders, T. J., Davidson, L. E. & Ross, R. Age-related changes in total and regional fat distribution. Ageing Res. Rev. 8, 339–348 (2009).
Kim, S. & Won, C. W. Sex-different changes of body composition in aging: a systemic review. Arch. Gerontol. Geriatr. 102, 104711 (2022).
Mott, J. W. et al. Relation between body fat and age in 4 ethnic groups. Am. J. Clin. Nutr. 69, 1007–1013 (1999).
Bray, G. A. Beyond BMI. Nutrients 15, 2254 (2023).
de Morais, N. S. et al. Body fat is superior to body mass index in predicting cardiometabolic risk factors in adolescents. Int. J. Environ. Res. Public Health 20, 2074 (2023).
Nevill, A. M., Duncan, M. J. & Myers, T. BMI is dead; long live waist-circumference indices: but which index should we choose to predict cardio-metabolic risk? Nutr. Metab. Cardiovasc. Dis. 32, 1642–1650 (2022).
Assyov, Y., Gateva, A., Tsakova, A. & Kamenov, Z. A comparison of the clinical usefulness of neck circumference and waist circumference in individuals with severe obesity. Endocr. Res. 42, 6–14 (2017).
Yamanaka, A. B. et al. Determination of child waist circumference cut points for metabolic risk based on acanthosis nigricans, the Children’s Healthy Living Program. Prev. Chronic Dis. 18, E64 (2021).
Do, J. Y. & Kang, S. H. Comparison of various indices for predicting sarcopenia and its components in patients receiving peritoneal dialysis. Sci. Rep. 12, 14102 (2022).
Ben-Noun, L., Sohar, E. & Laor, A. Neck circumference as a simple screening measure for identifying overweight and obese patients. Obes. Res. 9, 470–477 (2001).
Mohseni-Takalloo, S., Mozaffari-Khosravi, H., Mohseni, H., Mirzaei, M. & Hosseinzadeh, M. Evaluating neck circumference as an independent predictor of metabolic syndrome and its components among adults: a population-based study. Cureus 15, e40379 (2023).
Preis, S. R. et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart Study. J. Clin. Endocrinol. Metab. 95, 3701–3710 (2010).
Androutsos, O. et al. Neck circumference: a useful screening tool of cardiovascular risk in children. Pediatr. Obes. 7, 187–195 (2012).
Nafiu, O. O. et al. Neck circumference as a screening measure for identifying children with high body mass index. Pediatrics 126, e306–e310 (2010).
Kahn, H. S. Replacing the body mass index with the sagittal abdominal diameter (abdominal height). Obesity 31, 2720–2722 (2023).
Yim, J. Y. et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care 33, 2665–2670 (2010).
Kahn, H. S. & Cheng, Y. J. Comparison of adiposity indicators associated with fasting-state insulinemia, triglyceridemia, and related risk biomarkers in a nationally representative, adult population. Diabetes Res. Clin. Pract. 136, 7–15 (2018).
Lewandowski, Z., Dychała, E., Pisula-Lewandowska, A. & Danel, D. P. Comparison of skinfold thickness measured by caliper and ultrasound scanner in normative weight women. Int. J. Environ. Res. Public Health 19, 16230 (2022).
Hume, P. & Marfell-Jones, M. The importance of accurate site location for skinfold measurement. J. Sports Sci. 26, 1333–1340 (2008).
Mei, Z. et al. Do skinfold measurements provide additional information to body mass index in the assessment of body fatness among children and adolescents? Pediatrics 119, e1306–e1313 (2007).
Majmudar, M. D. et al. Smartphone camera based assessment of adiposity: a validation study. NPJ Digit. Med. 5, 79 (2022).
Affuso, O. et al. A method for measuring human body composition using digital images. PLoS ONE 13, e0206430 (2018).
Medina-Inojosa, J., Somers, V. K., Ngwa, T., Hinshaw, L. & Lopez-Jimenez, F. Reliability of a 3D body scanner for anthropometric measurements of central obesity. Obes. Open. Access 2, https://doi.org/10.16966/2380-5528.122 (2016).
Sager, R., Gusewell, S., Ruhli, F., Bender, N. & Staub, K. Multiple measures derived from 3D photonic body scans improve predictions of fat and muscle mass in young Swiss men. PLoS ONE 15, e0234552 (2020).
Jeon, S., Kim, M., Yoon, J., Lee, S. & Youm, S. Machine learning-based obesity classification considering 3D body scanner measurements. Sci. Rep. 13, 3299 (2023).
Kosilek, R. P. et al. Laser-based 3D body scanning reveals a higher prevalence of abdominal obesity than tape measurements: results from a population-based sample. Diagnostics 13, 2594 (2023).
Guarnieri Lopez, M., Matthes, K. L., Sob, C., Bender, N. & Staub, K. Associations between 3D surface scanner derived anthropometric measurements and body composition in a cross-sectional study. Eur. J. Clin. Nutr. 77, 972–981 (2023).
Garlie, T. N., Obusek, J. P., Corner, B. D. & Zambraski, E. J. Comparison of body fat estimates using 3D digital laser scans, direct manual anthropometry, and DXA in men. Am. J. Hum. Biol. 22, 695–701 (2010).
Cabre, H. E. et al. Validity of a 3-dimensional body scanner: comparison against a 4-compartment model and dual energy X-ray absorptiometry. Appl. Physiol. Nutr. Metab. 46, 644–650 (2021).
Harbin, M. M., Kasak, A., Ostrem, J. D. & Dengel, D. R. Validation of a three-dimensional body scanner for body composition measures. Eur. J. Clin. Nutr. 72, 1191–1194 (2018).
Dehghan, M. & Merchant, A. T. Is bioelectrical impedance accurate for use in large epidemiological studies? Nutr. J. 7, 26 (2008).
Mialich, M. S., Sicchieri, J. M. F. & Junior, A. A. J. Analysis of body composition: a critical review of the use of bioelectrical impedance analysis. Int. J. Clin. Nutr. 2, 1–10 (2014).
Jensky-Squires, N. E. et al. Validity and reliability of body composition analysers in children and adults. Br. J. Nutr. 100, 859–865 (2008).
Siedler, M. R. et al. Assessing the reliability and cross-sectional and longitudinal validity of fifteen bioelectrical impedance analysis devices. Br. J. Nutr. 130, 827–840 (2023).
Brunani, A. et al. Body composition assessment using bioelectrical impedance analysis (BIA) in a wide cohort of patients affected with mild to severe obesity. Clin. Nutr. 40, 3973–3981 (2021).
Ritz, P., Salle, A., Audran, M. & Rohmer, V. Comparison of different methods to assess body composition of weight loss in obese and diabetic patients. Diabetes Res. Clin. Pract. 77, 405–411 (2007).
Kreissl, A., Jorda, A., Truschner, K., Skacel, G. & Greber-Platzer, S. Clinically relevant body composition methods for obese pediatric patients. BMC Pediatr. 19, 84 (2019).
Fields, D. A., Goran, M. I. & McCrory, M. A. Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am. J. Clin. Nutr. 75, 453–467 (2002).
Francis, K. T. Body-composition assessment using underwater weighing techniques. Phys. Ther. 70, 657–662 (1990).
Chaves, L. et al. Assessment of body composition by whole-body densitometry: what radiologists should know. Radiol. Bras. 55, 305–311 (2022).
Damilakis, J., Adams, J. E., Guglielmi, G. & Link, T. M. Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur. Radiol. 20, 2707–2714 (2010).
Borga, M. et al. Advanced body composition assessment: from body mass index to body composition profiling. J. Investig. Med. 66, 1–9 (2018).
Heymsfield, S., Bell, J. D. & Heber, D. in Precision Nutrition: The Science and Promise of Personalized Nutrition and Health Ch. 7 (eds Heber, D., Li, Z. & Ordovas, J.) 143–152 (Academic Press, 2024).
Lee, S. B. et al. Automated segmentation of whole-body CT images for body composition analysis in pediatric patients using a deep neural network. Eur. Radiol. 32, 8463–8472 (2022).
Weston, A. D. et al. Automated abdominal segmentation of CT scans for body composition analysis using deep learning. Radiology 290, 669–679 (2019).
Yoo, H. J. et al. Deep learning-based fully automated body composition analysis of thigh CT: comparison with DXA measurement. Eur. Radiol. 32, 7601–7611 (2022).
Duan, K. et al. Effect of glucagon-like peptide-1 receptor agonists on fat distribution in patients with type 2 diabetes: a systematic review and meta-analysis. J. Diabetes Invest. 13, 1149–1160 (2022).
Wang, X., Wu, N., Sun, C., Jin, D. & Lu, H. Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetol. Metab. Syndr. 15, 113 (2023).
Verweij, L. M., Terwee, C. B., Proper, K. I., Hulshof, C. T. & van Mechelen, W. Measurement error of waist circumference: gaps in knowledge. Public. Health Nutr. 16, 281–288 (2013).
Pamoukdjian, F. et al. Obesity survival paradox in cancer patients: results from the Physical Frailty in Older Adult Cancer Patients (PF-EC) study. Clin. Nutr. 38, 2806–2812 (2019).
Keller, K., Munzel, T. & Ostad, M. A. Sex-specific differences in mortality and the obesity paradox of patients with myocardial infarction ages >70 y. Nutrition 46, 124–130 (2018).
de Miguel-Diez, J. et al. Obesity survival paradox in patients hospitalized with community-acquired pneumonia. Assessing sex-differences in a population-based cohort study. Eur. J. Intern. Med. 98, 98–104 (2022).
Butt, J. H. et al. Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox. Eur. Heart J. 44, 1136–1153 (2023).
Kvist, H., Chowdhury, B., Grangård, U., Tylén, U. & Sjöström, L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am. J. Clin. Nutr. 48, 1351–1361 (1988).
National Health and Nutrition Examination Survey (NHANES). Anthropometry Procedures Manual. wwwn.cdc.gov/nchs/data/nhanes/2019-2020/manuals/2020-Anthropometry-Procedures-Manual-508.pdf (CDC, 2020).
National Health and Nutrition Examination Survey (NHANES). Anthropometry Procedures Manual. wwwn.cdc.gov/nchs/data/nhanes/2013-2014/manuals/2013_anthropometry.pdf (CDC, 2013)
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
Tabesh, M. R. et al. Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: an updated comprehensive practical guideline. Obes. Surg. 33, 2557–2572 (2023).
Guerrero-Juarez, C. F. & Plikus, M. V. Emerging nonmetabolic functions of skin fat. Nat. Rev. Endocrinol. 14, 163–173 (2018).
Kahn, C. R., Wang, G. & Lee, K. Y. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J. Clin. Invest. 129, 3990–4000 (2019).
Rodríguez, A., Becerril, S., Hernández-Pardos, A. W. & Frühbeck, G. Adipose tissue depot differences in adipokines and effects on skeletal and cardiac muscle. Curr. Opin. Pharmacol. 52, 1–8 (2020).
Bruder-Nascimento, T., Kress, G, C. & Belin de Chantemele, E. J. Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function. F1000Res. 8, 1756 (2019).
Cesaro, A. et al. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. Front. Cardiovasc. Med. 10, 1187735 (2023).
Lee, Y. et al. The effect of omentectomy added to bariatric surgery on metabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. Surg. Obes. Relat. Dis. 14, 1766–1782 (2018).
Sotak, M. et al. Healthy subcutaneous and omental adipose tissue is associated with high expression of extracellular matrix components. Int. J. Mol. Sci. 23, 520 (2022).
Tchernof, A. & Despres, J. P. Pathophysiology of human visceral obesity: an update. Physiol. Rev. 93, 359–404 (2013).
Author information
Authors and Affiliations
Contributions
E.B. researched data for the article. All authors contributed substantially to discussion of the content. All authors wrote the article. All authors reviewed and/or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Endocrinology thanks Steven Heymsfield, Luis Moreno and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Börgeson, E., Tavajoh, S., Lange, S. et al. The challenges of assessing adiposity in a clinical setting. Nat Rev Endocrinol 20, 615–626 (2024). https://doi.org/10.1038/s41574-024-01012-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41574-024-01012-9